SCHEMBL6845262

SCHEMBL6845262

CC(C)c1ccc(S(=O)(=O)Nc2ccnc(NO)c2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 1/20 0.49
BRD1 O95696 1/20 0.49
BRPF1 P55201 1/20 0.49
PIK3C3 Q8NEB9 1/20 0.48
GFER P55789 1/20 0.47
POLB P06746 2/20 0.47
KIT P10721 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.46
ALDH1A1 P00352 3/20 0.46
MAPT P10636 2/20 0.46
LMNA P02545 1/20 0.46
PKM P14618 1/20 0.46
PGR P06401 1/20 0.45
GSK3B P49841 1/20 0.45
KDM4E B2RXH2 3/20 0.43
HTR6 P50406 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
TP53 P04637 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7573977 0.75 PKM (0.64) TRIM24BRD1BRPF1POLBKIT
SCHEMBL7835318 0.74 HTR6 (0.72) SMN1; SMN2ALDH1A1MAPTLMNAGSK3B
SCHEMBL11977002 0.73 KDM4E (0.70) POLBSMN1; SMN2ALDH1A1LMNAPKM
SCHEMBL7175064 0.72 HSD17B2 (0.67) TRIM24BRD1BRPF1GFERSMN1; SMN2
SCHEMBL7176650 0.71 LMNA (0.62) TRIM24BRD1BRPF1GFERPOLB
SCHEMBL14803278 0.71 AURKA (0.68) POLBSMN1; SMN2ALDH1A1MAPTLMNA
SCHEMBL31681359 0.71 LMNA (0.58) TRIM24BRD1BRPF1SMN1; SMN2ALDH1A1
SCHEMBL1415291 0.71 TRIM24 (0.58) TRIM24BRD1BRPF1POLBKIT
Hydrochloric Acid SCHEMBL1973363 0.70 TRIM24 (0.56) TRIM24BRD1BRPF1POLBKIT
SCHEMBL14349660 0.69 CA1 (0.61) TRIM24BRD1BRPF1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7867999-B1 Hydroxyamino- and amino-substituted pyridine analogs for treating rho kinase-mediated diseases and conditions ALCON RESEARCH, LTD. (US) 2011-01-11 US disclosed